🧬 Product Description

Alluvi Tirzepatide 40mg (R&D Only) is a premium research-grade dual agonist peptide designed exclusively for laboratory, analytical, and scientific investigation purposes in the UK. It is formulated to deliver high purity, batch consistency, and reliable performance in controlled research environments.

Tirzepatide is widely studied as a dual GIP and GLP-1 receptor agonist, making it one of the most important modern compounds for metabolic and endocrine research. This 40mg research vial is manufactured under strict quality control standards to ensure accuracy and reproducibility in experimental studies.

⚠️ This product is strictly for research use only (R&D Only) and is not intended for human or veterinary consumption.

---

🔬 Key Features

• 💎 High purity research-grade compound (≥99% HPLC verified standards)
• 🧪 Dual agonist mechanism (GLP-1 & GIP receptor pathways)
• 📦 40mg precision-formulated vial for laboratory studies
• 🧬 Consistent batch-to-batch reproducibility
• 🇬🇧 UK-focused research supply chain
• 📊 Ideal for metabolic, biochemical, and analytical research

---

⚗️ Ingredients / Composition

• Active Compound: Tirzepatide (40mg)
• Form: Lyophilized peptide powder
• Classification: Research chemical (dual receptor agonist)
• Purity: High-grade laboratory verified (≥99% typical specification)
• Excipients: Stabilizing agents for research integrity

---

🧠 Research Benefits (Scientific Use Only)

Alluvi Tirzepatide 40mg is widely utilized in non-clinical research environments for studying:

• Metabolic pathway interactions (GLP-1 & GIP activity)
• Insulin response signaling mechanisms
• Appetite regulation pathways (preclinical models)
• Energy balance and glucose metabolism research
• Pharmacokinetic and pharmacodynamic profiling

Recent scientific literature highlights Tirzepatide as a dual incretin agonist, making it a valuable reference compound in metabolic research models exploring glucose regulation and hormonal signalling pathways.

---

📊 Recommended Usage (Research Protocol Only)

For laboratory reference use only:

• Designed for in-vitro and analytical studies
• Typically used in controlled, measured micro-dosing research models
• Requires standard laboratory dilution and handling protocols
• Store at 2–8°C refrigerated conditions
• Avoid repeated freeze-thaw cycles

⚠️ Not for injection, human use, or therapeutic application.

---

🔗 Stacking Options (Research Context)

In controlled research environments, Tirzepatide is often studied alongside:

• GLP-1 receptor agonist comparators (e.g., semaglutide analogues)
• GIP pathway research compounds
• Metabolic pathway modifiers
• Insulin sensitivity study agents

These combinations are used purely for comparative metabolic research and receptor interaction analysis.

---

⚠️ Safety & Precautions

• For laboratory research only
• Not approved for human or veterinary use
• Handle using standard laboratory PPE
• Avoid ingestion, inhalation, or direct contact
• Store securely in a controlled environment
• Dispose of according to laboratory chemical safety guidelines

Improper handling may lead to contamination or loss of compound integrity.

---

⭐ Why Buy From Us?

Choosing our supply ensures:

• ✔ Consistent research-grade purity and verification
• ✔ Reliable UK-based distribution
• ✔ Secure and discreet packaging
• ✔ Strict R&D-only compliance labeling
• ✔ High-quality batch traceability systems
• ✔ Fast processing for UK research buyers

We prioritize scientific accuracy, stability, and reliability, ensuring your research outcomes remain consistent and reproducible.